BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 24121886)

  • 1. [The FAME 2 study].
    Fineschi M; Marzilli M; Huqi A
    G Ital Cardiol (Rome); 2013 Oct; 14(10):636-40. PubMed ID: 24121886
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of stable angina pectoris. "Mother Courage and her children"].
    Nagy V; Czuriga I
    Orv Hetil; 2008 Feb; 149(7):291. PubMed ID: 18258558
    [No Abstract]   [Full Text] [Related]  

  • 3. [The evidence-based invasive therapy of stable angina pectoris].
    Becker D; Merkely B
    Orv Hetil; 2008 Feb; 149(7):299-304. PubMed ID: 18258560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Should we revascularize patients with moderate coronary lesions and borderline fractional flow reserve measurements?
    Zijlstra F
    Catheter Cardiovasc Interv; 2008 Mar; 71(4):549-50. PubMed ID: 18307225
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evidence-based optimal treatment strategy of patients with angina pectoris].
    Jánosi A
    Orv Hetil; 2008 Feb; 149(7):293-8. PubMed ID: 18258559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The CHAMPION PHOENIX study].
    Musumeci G; Limbruno U
    G Ital Cardiol (Rome); 2013 Oct; 14(10):641-6. PubMed ID: 24121887
    [No Abstract]   [Full Text] [Related]  

  • 7. [Stable coronary heart disease--lessons from the COURAGE Study. With intensive drug therapy on the success track].
    MMW Fortschr Med; 2008 Jun; 150(23):38-9. PubMed ID: 18575368
    [No Abstract]   [Full Text] [Related]  

  • 8. Current indications for percutaneous coronary intervention for chronic stable angina: implications of the COURAGE Trial.
    Kiernan TJ; Prasad A; Gersh BJ
    Rev Cardiovasc Med; 2007; 8(4):234-9. PubMed ID: 18192947
    [No Abstract]   [Full Text] [Related]  

  • 9. Will this trial change my practice? PRAMI - treatment of bystander coronary lesions in patients undergoing primary PCI for acute STEMI.
    Toth GG; Kala P; Lansky A; Baumbach A
    EuroIntervention; 2014 Jul; 10(3):411-2. PubMed ID: 25042272
    [No Abstract]   [Full Text] [Related]  

  • 10. Percutaneous coronary intervention for left main coronary artery disease.
    Gauthier N; Le May MR
    Expert Rev Cardiovasc Ther; 2007 Mar; 5(2):213-20. PubMed ID: 17338666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Heart catheter in stable coronary heart disease. Drugs are equally effective].
    Einecke D
    MMW Fortschr Med; 2007 Apr; 149(15):10, 12. PubMed ID: 17668771
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: One year perspective on COURAGE.
    Sedlis SP; Boden WE; Weintraub WS; Maron DS; O'Rourke RA; Berman DS; Mancini GB;
    Catheter Cardiovasc Interv; 2009 Feb; 73(3):428. PubMed ID: 19133682
    [No Abstract]   [Full Text] [Related]  

  • 13. COURAGE to make choices. When it comes to treating angina or a narrowed coronary artery, angioplasty is no better than medical therapy for preventing heart attacks or premature death.
    Harv Heart Lett; 2007 Jun; 17(10):5. PubMed ID: 17654799
    [No Abstract]   [Full Text] [Related]  

  • 14. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease.
    Hueb W; Lopes NH; Gersh BJ; Soares P; Machado LA; Jatene FB; Oliveira SA; Ramires JA
    Circulation; 2007 Mar; 115(9):1082-9. PubMed ID: 17339566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous coronary intervention versus conservative therapy in nonacute coronary artery disease: a meta-analysis.
    Katritsis DG; Ioannidis JP
    Circulation; 2005 Jun; 111(22):2906-12. PubMed ID: 15927966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Six-year status quo with fractional flow reserve.
    Rioufol G; Finet G
    Arch Cardiovasc Dis; 2010 Jan; 103(1):57-8. PubMed ID: 20142123
    [No Abstract]   [Full Text] [Related]  

  • 17. [Coronary physiology and its usefulness for the interventionist cardiologist: invasive measurement of coronary flow-pressure].
    Barrera-Ramírez CF; Escaned J
    Arch Cardiol Mex; 2005; 75(3):335-49. PubMed ID: 16294824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of patients with stable angina pectoris treated with or without percutaneous coronary intervention.
    Gu Y; Hu Y; Hu L; Cheng Z; Li L
    Cardiol J; 2008; 15(3):226-9. PubMed ID: 18651414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of optimal medical therapy and percutaneous coronary intervention on patients with stable angina.
    Latib A; Chieffo A; Colombo A
    Nat Clin Pract Cardiovasc Med; 2009 Feb; 6(2):92-3. PubMed ID: 19065124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful high-risk percutaneous coronary revascularization using Impella Recover LP 5.0 l/min.
    Sciahbasi A; Pendenza G; Romagnoli E; Summaria F; Chiappa R; Patrizi R; Caselli G; Lioy E
    J Cardiovasc Med (Hagerstown); 2013 May; 14(5):388-92. PubMed ID: 20035234
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.